Steroids for Community-Acquired PneumoniaCommunity Acquired PneumoniaLactamsInitial ChoicesSystematic ReviewsRandomised Controlled TrialsRelative RisksTreatment FailuresAn abstract is unavailable.doi:10.1097/IPC.0000000000000330FileThomas M.Infectious Diseases in Clin...
The article discusses the benefits of steroid use as an adjunctive therapy for patients diagnosed with community-acquired pneumonia (CAP). Information provided include how steroid can improve outcomes CAP treatment, such as reduced hospital length of stay, decreased time to clinical stability, and lowe...
Myths in Emergency Medicine: 24-Hour Treatment with Antibiotics for Strep Throat Explore This Issue ACEP Now: Vol 39 – No 11 – November 2020 Question 2: In children with confirmed group A strep pharyngitis, do steroids shorten duration and severity of the illness? With winter beginning, st...
Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (A... To determine whether oral corticosteroids can prevent early deterioration in patients with acquired immunodeficiency syndrome (AIDS)-related Pneumocystis c....
Community-Acquired MRSA Pneumonia in an Urban Community Hospital: Risk Factors, Presentation, and Outcomes All but one had significant comorbidities, including chronic lung disease (35%), cardiac disease (24%), diabetes mellitus (59%) and AIDS (6%). Significant medications included oral steroids (...
The article discusses aspects of how corticosteroids affect treatment failure in hospitalized patients with severe community-acquired pneumonia with high inflammatory response.WatkinsDivisionRichardDivisionR.DivisionEBSCO_AspInternal Medicine Alert
Adjuvant therapies in critical care: steroids in community-acquired pneumonia.doi:10.1007/S00134-017-4967-XAntoni TorresMiquel FerrerMichael S. NiedermanSpringer Berlin Heidelberg
Background: Steroid administration has been used as an adjunctive therapy in severe community-acquired pneumonia (SCAP), but there is limited evidence from developing countries to support their use. This study aimed to determine the effects of systemic steroids in patients with community-acquired ...
Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality despite adequate antibiotic therapy. It is the single most common cause of infection-related mortality in the United States. An exaggerated host inflammatory response can potentially be harmful to both the lung and host...
doi:10.1024/1661-8157/a002055JohannSteurerEBSCO_AspPraxis